These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8098425)
21. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Bouchaud O; Basco LK; Gillotin C; Gimenez F; Ramiliarisoa O; Genissel B; Bouvet E; Farinotti R; Le Bras J; Coulaud JP Am J Trop Med Hyg; 1994 Aug; 51(2):204-13. PubMed ID: 8074254 [TBL] [Abstract][Full Text] [Related]
22. Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model. Singh N; Puri SK Life Sci; 2000 Aug; 67(11):1345-54. PubMed ID: 10972203 [TBL] [Abstract][Full Text] [Related]
23. Antimalarial drug resistance and mortality in falciparum malaria. White N Trop Med Int Health; 1999 Jul; 4(7):469-70. PubMed ID: 10470336 [No Abstract] [Full Text] [Related]
24. [Drug resistant tropical malaria in the Republic of Guinea (West Africa)]. Popov AF; Popova NI; Chirkov VP; Kamara F Med Parazitol (Mosk); 2003; (2):41-3. PubMed ID: 12886592 [No Abstract] [Full Text] [Related]
25. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment. Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582 [TBL] [Abstract][Full Text] [Related]
27. Editorial: antimalarial drug discovery and design in the era of resistance. Bell A Curr Pharm Des; 2013; 19(2):264-5. PubMed ID: 22973889 [No Abstract] [Full Text] [Related]
28. [Cross resistance to mefloquine and halofantrine in a case of P. falciparum malaria contracted in Sierra Leone]. Félix R; Gay F; Lyogoubi A; Bustos MD; Diquet B; Danis M; Gentilini M Bull Soc Pathol Exot; 1990; 83(1):43-5. PubMed ID: 2190703 [TBL] [Abstract][Full Text] [Related]
29. [Is the in vivo test for resistance to antimalarial agents in malaria as defined by the WHO valid?]. Cabezos J; Bada JL; Asmarats L Med Clin (Barc); 1992 Oct; 99(11):436. PubMed ID: 1469944 [No Abstract] [Full Text] [Related]
30. Chloroquine resistant Plasmodium falciparum in migrant population. Srivastava HC; Sharma SK Indian J Malariol; 2000; 37(1-2):39-42. PubMed ID: 11820081 [No Abstract] [Full Text] [Related]
31. Activity in vitro of the enantiomers of halofantrine. Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J Trans R Soc Trop Med Hyg; 1993; 87(1):78-9. PubMed ID: 8465405 [No Abstract] [Full Text] [Related]
32. [Drug sensitivity of Plasmodium falciparum in vivo and in vitro in Brazzaville (Congo)]. Chandenier J; Ndounga M; Carme B; Gay F; Mbitsi A; Hayette MP; Stanghellini A; Ossoh JO; Baudon D; Zitsamélé RC Sante; 1995; 5(1):25-9. PubMed ID: 7894826 [TBL] [Abstract][Full Text] [Related]
33. Chloroquine resistant malaria in children. Memon IA; Kanth N; Murtaza G J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043 [TBL] [Abstract][Full Text] [Related]
34. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar. Al-Yaman F; Genton B; Mokela D; Alpers MP P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730 [No Abstract] [Full Text] [Related]
35. Population genetics: malaria variorum. Clark AG Nature; 2002 Jul; 418(6895):283-5. PubMed ID: 12124606 [No Abstract] [Full Text] [Related]
36. First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America. Legrand E; Demar M; Volney B; Ekala MT; Quinternet M; Bouchier C; Fandeur T; Rogier C; Carme B; Puijalon OM; Esterre P Antimicrob Agents Chemother; 2007 Jun; 51(6):2280-1. PubMed ID: 17438062 [No Abstract] [Full Text] [Related]